Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials.

Newman CB, Carmichael JD, Kleinberg DL.

Pituitary. 2014 May 9. [Epub ahead of print]

PMID:
24810900
[PubMed - as supplied by publisher]
2.

Dose-dependent changes in body composition during growth hormone (GH) treatment in Japanese patients with adult GH deficiency: a randomized, placebo-controlled trial.

Chihara K, Fujieda K, Shimatsu A, Miki T, Tachibana K.

Growth Horm IGF Res. 2010 Jun;20(3):205-11. doi: 10.1016/j.ghir.2010.01.003. Epub 2010 Feb 21.

PMID:
20176498
[PubMed - indexed for MEDLINE]
3.

Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.

Hansen TB, Gram J, Jensen PB, Kristiansen JH, Ekelund B, Christiansen JS, Pedersen FB.

Clin Nephrol. 2000 Feb;53(2):99-107.

PMID:
10711411
[PubMed - indexed for MEDLINE]
4.

Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2008 Aug;18(4):307-17. doi: 10.1016/j.ghir.2007.12.001. Epub 2008 Feb 20.

PMID:
18282776
[PubMed - indexed for MEDLINE]
5.

Moderate doses of hGH (0.64 mg/d) improve lipids but not cardiovascular function in GH-deficient adults with normal baseline cardiac function.

Newman CB, Frisch KA, Rosenzweig B, Roubenoff R, Rey M, Kidder T, Kong Y, Pursnani A, Sedlis SP, Schwartzbard A, Kleinberg DL.

J Clin Endocrinol Metab. 2011 Jan;96(1):122-32. doi: 10.1210/jc.2010-1204. Epub 2010 Oct 6.

PMID:
20926529
[PubMed - indexed for MEDLINE]
6.

Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency.

Abrahamsen B, Nielsen TL, Hangaard J, Gregersen G, Vahl N, Korsholm L, Hansen TB, Andersen M, Hagen C.

Eur J Endocrinol. 2004 May;150(5):671-9.

PMID:
15132723
[PubMed - indexed for MEDLINE]
Free Article
7.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
[PubMed - indexed for MEDLINE]
8.

Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.

Rodríguez-Arnao J, Jabbar A, Fulcher K, Besser GM, Ross RJ.

Clin Endocrinol (Oxf). 1999 Jul;51(1):53-60.

PMID:
10468965
[PubMed - indexed for MEDLINE]
9.

Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.

Underwood LE, Attie KM, Baptista J; Genentech Collaborative Study Group.

J Clin Endocrinol Metab. 2003 Nov;88(11):5273-80.

PMID:
14602761
[PubMed - indexed for MEDLINE]
10.

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P; Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials.

J Clin Endocrinol Metab. 2004 May;89(5):2192-9.

PMID:
15126541
[PubMed - indexed for MEDLINE]
11.

Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study.

Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.

Growth Horm IGF Res. 2006 Apr;16(2):132-42. Epub 2006 May 15.

PMID:
16702006
[PubMed - indexed for MEDLINE]
12.

Effect of growth hormone treatment on trunk fat accumulation in adult GH-deficient Japanese patients: a randomised, placebo-controlled trial.

Chihara K, Kato Y, Takano K, Shimatsu A, Kohno H, Tanaka T, Irie M.

Curr Med Res Opin. 2006 Oct;22(10):1973-9.

PMID:
17022857
[PubMed - indexed for MEDLINE]
13.

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D.

J Clin Endocrinol Metab. 1998 Jan;83(1):107-16.

PMID:
9435425
[PubMed - indexed for MEDLINE]
14.

Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.

Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG.

Clin Endocrinol (Oxf). 1995 Jan;42(1):73-84.

PMID:
7889635
[PubMed - indexed for MEDLINE]
15.

Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study.

Hansen TB, Vahl N, Jørgensen JO, Christiansen JS, Hagen C.

Clin Endocrinol (Oxf). 1995 Dec;43(6):689-96.

PMID:
8736270
[PubMed - indexed for MEDLINE]
16.

Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.

Jørgensen JO, Vahl N, Hansen TB, Thuesen L, Hagen C, Christiansen JS.

Clin Endocrinol (Oxf). 1996 Dec;45(6):681-8.

PMID:
9039333
[PubMed - indexed for MEDLINE]
17.

The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial.

Nolte W, Rädisch C, Armstrong VW, Hüfner M, von zur Mühlen A.

Eur J Endocrinol. 1997 Nov;137(5):459-66.

PMID:
9405024
[PubMed - indexed for MEDLINE]
Free Article
18.

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.

Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9.

PMID:
11012570
[PubMed - indexed for MEDLINE]
19.

Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.

Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebl J, Chipman JJ, Shalet SM; Hypopituitary Developmental Outcome Study Group.

J Clin Endocrinol Metab. 2004 Oct;89(10):4857-62.

PMID:
15472176
[PubMed - indexed for MEDLINE]
20.

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA.

Clin Endocrinol (Oxf). 1997 Oct;47(4):439-46.

PMID:
9404442
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk